Carl Zeiss Meditec AG Statistics

Total Valuation

Carl Zeiss Meditec AG has a market cap or net worth of GBP 4.32 billion. The enterprise value is 4.78 billion.

Market Cap	4.32B
Enterprise Value	4.78B

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	Mar 22, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.66%
Shares Change (QoQ)	-2.80%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	34.63M

Valuation Ratios

The trailing PE ratio is 29.06.

PE Ratio	29.06
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	6.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.01, with an EV/FCF ratio of 35.79.

EV / Earnings	32.15
EV / Sales	2.77
EV / EBITDA	23.01
EV / EBIT	31.01
EV / FCF	35.79

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.27.

Current Ratio	2.13
Quick Ratio	1.06
Debt / Equity	0.27
Debt / EBITDA	2.20
Debt / FCF	3.45
Interest Coverage	6.37

Financial Efficiency

Return on equity (ROE) is 8.52% and return on invested capital (ROIC) is 4.74%.

Return on Equity (ROE)	8.52%
Return on Assets (ROA)	3.65%
Return on Invested Capital (ROIC)	4.74%
Return on Capital Employed (ROCE)	6.64%
Revenue Per Employee	300,055
Profits Per Employee	25,956
Employee Count	5,730
Asset Turnover	0.64
Inventory Turnover	1.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.09% in the last 52 weeks. The beta is 1.04, so Carl Zeiss Meditec AG's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-41.09%
50-Day Moving Average	52.18
200-Day Moving Average	66.19
Relative Strength Index (RSI)	70.75
Average Volume (20 Days)	28,425

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Carl Zeiss Meditec AG had revenue of GBP 1.72 billion and earned 148.73 million in profits. Earnings per share was 1.67.

Revenue	1.72B
Gross Profit	905.90M
Operating Income	155.95M
Pretax Income	200.44M
Net Income	148.73M
EBITDA	187.27M
EBIT	155.95M
Earnings Per Share (EPS)	1.67

Full Income Statement

Balance Sheet

The company has 16.88 million in cash and 460.86 million in debt, giving a net cash position of -443.98 million.

Cash & Cash Equivalents	16.88M
Total Debt	460.86M
Net Cash	-443.98M
Net Cash Per Share	n/a
Equity (Book Value)	1.71B
Book Value Per Share	19.41
Working Capital	535.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 205.80 million and capital expenditures -72.24 million, giving a free cash flow of 133.56 million.

Operating Cash Flow	205.80M
Capital Expenditures	-72.24M
Free Cash Flow	133.56M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 52.69%, with operating and profit margins of 9.07% and 8.65%.

Gross Margin	52.69%
Operating Margin	9.07%
Pretax Margin	11.66%
Profit Margin	8.65%
EBITDA Margin	10.89%
EBIT Margin	9.07%
FCF Margin	7.77%

Dividends & Yields

Carl Zeiss Meditec AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-2.91%
Years of Dividend Growth	n/a
Payout Ratio	54.95%
Buyback Yield	0.66%
Shareholder Yield	0.66%
Earnings Yield	3.44%
FCF Yield	3.09%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Carl Zeiss Meditec AG has an Altman Z-Score of 5.11.

Altman Z-Score	5.11
Piotroski F-Score	n/a